Global Economy

US regulator FDA clears Johnson & Johnson's single-dose COVID vaccine for emergency use

U.S. regulators on Saturday authorized a third COVID-19 vaccine, a single-dose shot by Johnson & Johnson that could help speed vaccinations. The move by the Food and Drug Administration came after an expert panel debated the evidence to allow widespread use of J&J’s vaccine. J&J has said it can supply enough to vaccinate 20 million people by the end of March.


Read More   A look inside Chan Zuckerberg, the philanthropic project funded by billions in Facebook stock sales

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.